Nimotuzumab induces NK cell activation, cytotoxicity, dendritic cell maturation and expansion of EGFR-specific T cells in head and neck cancer patients

Article

Abstract: Survival benefit and long-term duration of clinical response have been seen using the epidermal grow

Palabras claves:

head and neck cancer, Human epidermal growth factor receptor, monoclonal antibodies, Natural killer cells, T cells

Autores:

Barroso M.C., Concha-Benavente F., Cuevas I., Ferris R.L., Frómeta C., García-Bates T.M., González A., Gonzalez Z., Hechavarría E., Lavastida A., Lugiollo M., Mazorra Z., Mestre B.F., Srivastava R.M., Tania Crombet, Valdés A.

Fuentes:

scopus